MktsMarkets

Cogent Biosciences, Inc.
NASDAQ: COGTKey statistics
COGT News
Stories mentioning COGT from around the web — every one is an open thread, so give it a like or add your take.
Loading news…
Financial statements
As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.
| Line item | Q1 '26Mar 31 | Q4 '25Dec 31 | Q3 '25Sep 30 | Q2 '25Jun 30 | Q1 '25Mar 31 | Q4 '24Dec 31 | Q3 '24Sep 30 | Q2 '24Jun 30 |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | ||||||||
| Cost of Goods Sold | ||||||||
| Gross Profit | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | ||||||||
| Research & Development | 75,365 | 75,559 | 68,989 | 62,203 | 63,029 | 62,045 | 63,614 | 54,294 |
| Sales General & Admin | ||||||||
| Total Operating Expenses | ||||||||
| Operating Income (Loss) | (103,607) | (99,493) | (83,355) | (75,582) | (74,933) | (73,734) | (75,414) | (64,387) |
| Interest Income | 7,608 | 5,477 | 3,887 | 2,373 | 2,952 | 3,859 | 4,779 | 5,393 |
| Interest Expense | ||||||||
| Other Expense | (140.00) | (6.00) | (3.00) | (6.00) | (5.00) | 1,948 | 1.00 | 44.00 |
| Pretax Income | ||||||||
| Tax Provision | ||||||||
| Net Income (Loss) | (97,352) | (102,492) | (80,930) | (73,529) | (71,986) | (67,927) | (70,634) | (58,950) |
| Earnings Per Share (Basic) | (0.53) | (0.80) | (0.50) | (0.53) | (0.52) | (0.65) | (0.52) | (0.43) |
| Earnings Per Share (Diluted) | (0.53) | (0.80) | (0.50) | (0.53) | (0.52) | (0.65) | (0.52) | (0.43) |
| Weighted Average Shares Outstanding (Basic) | 162,195 | 128,899 | 137,550 | 114,466 | 113,308 | 103,857 | 110,166 | 99,240 |
| Weighted Average Shares Outstanding (Diluted) | 162,195 | 128,899 | 137,550 | 114,466 | 113,308 | 103,857 | 110,166 | 99,240 |
Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.
About COGT
Cogent Biosciences, Inc. (NASDAQ: COGT) is a stock listed on the Nasdaq Stock Market under the ticker symbol COGT. It last traded at $31.96 (Oct 29, 2026, 4:00 PM ET), down 0.8% on the day. That gives Cogent Biosciences a market capitalisation of $5.5B.
Over the past 52 weeks COGT has traded between $13.78 and $43.73.
For the quarter ended Mar 31, 2026 it reported a net loss of $97.4M.
| Quarter ended | Revenue | Net income |
|---|---|---|
| Mar 31, 2026 | — | -$97.4M |
| Dec 31, 2025 | — | -$102.5M |
| Sep 30, 2025 | — | -$80.9M |
| Jun 30, 2025 | — | -$73.5M |
From Cogent Biosciences’s quarterly (10-Q) filings, in US dollars.
Take a break — play a market game
Seven free games built around the markets. No download, no sign-up: they run right here in your browser.
Latest News
Market news from around the web — every story is an open thread, so give it a like or add your take.
Loading news…